Fungal co-infection in COVID-19 patients: Should we be concerned?

Here’s a detailed summary of the study “Fungal co-infection in COVID-19 patients: Should we be concerned?” from the Revista Iberoamericana de Micología: Background The study addresses concerns about fungal co-infections in critically ill COVID-19 patients, focusing on invasive fungal infections (IFI) such as invasive pulmonary aspergillosis (IPA), invasive candidiasis (IC), and Pneumocystis jirovecii pneumonia (PJP). Due to immune dysregulation and high pro- and anti-inflammatory cytokine levels in severely ill COVID-19 patients, there is an increased risk of these infections. The research highlights the lack of comprehensive studies on fungal co-infections in COVID-19 patients​​. COVID-19-Associated Pulmonary Aspergillosis (CAPA) Challenges in Diagnosing…